Legal cannabis laws, home cultivation, and use of edible cannabis products: A growing relationship?

International Journal of Drug Policy

Volumn 50, Issue , 2017, Pages 102-110

  Borodovsky, Jacob T ^a,b   Budney, Alan J ^a  

^a DARTMOUTH MEDICAL SCHOOL   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

Author keywords

Cannabis; Dispensary; Edibles; Facebook; Home cultivation; Legalization

Indexed keywords

CANNABIS;

ADULT; AGRICULTURAL PROCEDURES; ARTICLE; CANNABIS USE; DRUG LEGISLATION; EDIBLE PLANT; FEMALE; HOME CULTIVATION; HUMAN; MALE; PRIORITY JOURNAL; PURCHASING; UNITED STATES; ADOLESCENT; AGRICULTURE; COMMERCIAL PHENOMENA; LEGISLATION AND JURISPRUDENCE; MIDDLE AGED; QUESTIONNAIRE; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADOLESCENT; ADULT; AGRICULTURE; CANNABIS; COMMERCE; FEMALE; HUMANS; LEGISLATION, DRUG; MALE; MARIJUANA USE; MIDDLE AGED; PLANTS, EDIBLE; SURVEYS AND QUESTIONNAIRES; YOUNG ADULT;

EID: 85032922265     PISSN: 09553959     EISSN: 18734758     Source Type: Journal    
DOI: 10.1016/j.drugpo.2017.09.014     Document Type: Article

References (59)

1. Barratt, M.J., Bouchard, M., Decorte, T., Asmussen Frank, V., Hakkarainen, P., Lenton, S., et al. Understanding global patterns of domestic cannabis cultivation. Drugs and Alcohol Today 12 (2012), 213–221.
2. Barratt, M.J., Potter, G.R., Wouters, M., Wilkins, C., Werse, B., Perala, J., et al. Lessons from conducting trans-national internet-mediated participatory research with hidden populations of cannabis cultivators. International Journal of Drug Policy 26 (2015), 238–249.
3. Barrus, D.G., Capogrossi, K.L., Cates, S.C., Gourdet, C.K., Peiper, N.C., Novak, S.P., et al. Tasty THC: Promises and challenges of cannabis edibles. Methods Report RTI Press, 2016, 1–17, 10.3768/rtipress.2016.op.0035.1611.
4. Barry, R.A., Glantz, S., A public health framework for legalized retail marijuana based on the US experience: Avoiding a new tobacco industry. PLoS Medicine, 13, 2016, e1002131.
5. Bell, C., Slim, J., Flaten, H.K., Lindberg, G., Arek, W., Monte, A.A., Butane hash oil burns associated with marijuana liberalization in colorado. Journal of Medical Toxicology 11 (2015), 422–425.
6. Bestrashniy, J., Winters, K.C., Variability in medical marijuana laws in the United States. Psychology of Addictive Behaviors 29 (2015), 639–642.
7. Borodovsky, J.T., Crosier, B.S., Lee, D.C., Sargent, J.D., Budney, A.J., Smoking, vaping, eating: Is legalization impacting the way people use cannabis?. International Journal of Drug Policy 36 (2016), 141–147.
8. Borodovsky, J.T., Lee, D.C., Crosier, B.S., Gabrielli, J.L., Sargent, J.D., Budney, A.J., U.S. cannabis legalization and use of vaping and edible products among youth. Drug and Alcohol Dependence 177 (2017), 299–306.
9. Cao, D., Srisuma, S., Bronstein, A.C., Hoyte, C.O., Characterization of edible marijuana product exposures reported to United States poison centers. Clinical Toxicology (Philadelphia) 54 (2016), 840–846.
10. Carlini, B.H., Garrett, S.B., Harwick, R.M., Beyond joints and brownies: Marijuana concentrates in the legal landscape of WA State. International Journal of Drug Policy 42 (2017), 26–29.
11. Caulkins, J.P., Kilmer, B., MacCoun, R.J., Pacula, R.L., Reuter, P., Design considerations for legalizing cannabis: Lessons inspired by analysis of California's Proposition 19. Addiction 107 (2012), 865–871.
12. Center for Behavioral Health Statistics and Quality. (2015). Behavioral Health Trends in the United States: Results from the 2014 National Survey on Drug Use and Health. In.
13. Cerda, M., Wall, M., Keyes, K.M., Galea, S., Hasin, D., Medical marijuana laws in 50 states: Investigating the relationship between state legalization of medical marijuana and marijuana use, abuse and dependence. Drug and Alcohol Dependence 120 (2012), 22–27.
14. Chapman, S.A., Spetz, J., Lin, J., Chan, K., Schmidt, L.A., Capturing heterogeneity in medical marijuana policies: A taxonomy of regulatory regimes across the United States. Substance Use and Misuse 51 (2016), 1174–1184.
15. Choo, E.K., Emery, S.L., Clearing the haze: The complexities and challenges of research on state marijuana laws. Annals of the New York Academy of Sciences 1394 (2017), 55–73.
16. Colorado.gov. MED Licensed Facilities. Retrieved 9.14.16 from https://www.colorado.gov/pacific/enforcement/med-licensed-facilities.
17. comScore, & Statista Distribution of Facebook users in the United States as of December 2016, by age group. 2017 from https://www.statista.com/statistics/187549/facebook-distribution-of-users-age-group-usa/.
18. Daniulaityte, R., Nahhas, R.W., Wijeratne, S., Carlson, R.G., Lamy, F.R., Martins, S.S., et al. Time for dabs: Analyzing Twitter data on marijuana concentrates across the U.S. Drug and Alcohol Dependence 155 (2015), 307–311.
19. Decorte, T., Potter, G.R., The globalisation of cannabis cultivation: A growing challenge. International Journal of Drug Policy 26 (2015), 221–225.
20. Decorte, T., The case for small-scale domestic cannabis cultivation. International Journal of Drug Policy 21 (2010), 271–275.
21. Decorte, T., Cannabis social clubs in Belgium: Organizational strengths and weaknesses, and threats to the model. International Journal of Drug Policy 26 (2015), 122–130.
22. Di Forti, M., Sallis, H., Allegri, F., Trotta, A., Ferraro, L., Stilo, S.A., et al. Daily use, especially of high-potency cannabis, drives the earlier onset of psychosis in cannabis users. Schizophrenia Bulletin 40 (2014), 1509–1517.
23. Doorenbos, N.J., Fetterman, P.S., Quimby, M.W., Turner, C.E., Annals of the New York academy of sciences. CULTIVATION, EXTRACTION: AND ANALYSIS OF CANNABIS SATIVA L. Annals of the New York Academy of Sciences 191 (1971), 3–14.
24. Freeman, T.P., Winstock, A.R., Examining the profile of high-potency cannabis and its association with severity of cannabis dependence. Psychological Medicine 45 (2015), 3181–3189.
25. Ghosh, T.S., Van Dyke, M., Maffey, A., Whitley, E., Erpelding, D., Wolk, L., Medical marijuana's public health lessons–implications for retail marijuana in Colorado. New England Journal of Medicine 372 (2015), 991–993.
26. Harper, S., Strumpf, E.C., Kaufman, J.S., Do medical marijuana laws increase marijuana use? Replication study and extension. Annals of Epidemiology 22 (2012), 207–212.
27. Hunt, P.E., Miles, J., The impact of legalizing and regulating weed: Issues with study design and emerging findings in the USA. Curr top behav neurosci (2016/01/01 ed., pp. 1–26), 2015, Springer Berlin Heidelberg, Berlin, Heidelberg.
28. Loflin, M., Earleywine, M., A new method of cannabis ingestion: The dangers of dabs?. Addictive Behaviors 39 (2014), 1430–1433.
29. Lynne-Landsman, S.D., Livingston, M.D., Wagenaar, A.C., Effects of state medical marijuana laws on adolescent marijuana use. American Journal of Public Health 103 (2013), 1500–1506.
30. Lynskey, M.T., Hindocha, C., Freeman, T.P., Legal regulated markets have the potential to reduce population levels of harm associated with cannabis use. Addiction 111 (2016), 2091–2092.
31. MacCoun, R.J., Mello, M.M., Half-baked–the retail promotion of marijuana edibles. New England Journal of Medicine 372 (2015), 989–991.
32. Marijuana Enforcement Division, Retail marijuana rules. 1 CCR 212-2, 2017, Colorado Department of Revenue: Secretary of State.
33. Oregon Liquor Control Commission. (2016). Medical and recreational marijuana packaging and labeling guide 2.0 In.
34. Pacula, R.L., Hunt, P., Boustead, A., Words can be deceiving: A review of variation among legally effective medical marijuana laws in the United States. Journal of Drug Policy Analysis 7 (2014), 1–19.
35. Pacula, R.L., Kilmer, B., Wagenaar, A.C., Chaloupka, F.J., Caulkins, J.P., Developing public health regulations for marijuana: Lessons from alcohol and tobacco. American Journal of Public Health 104 (2014), 1021–1028.
36. Pacula, R.L., Powell, D., Heaton, P., Sevigny, E.L., Assessing the effects of medical marijuana laws on marijuana use: The devil is in the details. Journal of Policy Analysis and Management 34 (2015), 7–31.
37. Pierre, J.M., Gandal, M., Son, M., Cannabis-induced psychosis associated with high potency wax dabs. Schizophrenia Research 172 (2016), 211–212.
38. Potter, G.R., Barratt, M.J., Malm, A., Bouchard, M., Blok, T., Christensen, A.S., et al. Global patterns of domestic cannabis cultivation: Sample characteristics and patterns of growing across eleven countries. International Journal of Drug Policy 26 (2015), 226–237.
39. ProCon.org. 28 Legal Medical Marijuana States and D.C. Retrieved 1.24.2017 from http://medicalmarijuana.procon.org/view.resource.php?resourceID=000881.
40. Ramo, D.E., Liu, H., Prochaska, J.J., Reliability and validity of young adults’ anonymous online reports of marijuana use and thoughts about use. Psychology of Addictive Behaviors 26 (2012), 801–811.
41. Ramo, D.E., Rodriguez, T.M., Chavez, K., Sommer, M.J., Prochaska, J.J., Facebook recruitment of young adult smokers for a cessation trial: Methods, metrics and lessons learned. Internet Interventions 1 (2014), 58–64.
42. Richter, K.P., Levy, S., Big marijuana-lessons from big tobacco. New England Journal of Medicine 371 (2014), 399–401.
43. Romanowski, K.S., Barsun, A., Kwan, P., Teo, E.H., Palmieri, T.L., Sen, S., et al. Butane hash oil burns: A 7-Year perspective on a growing problem. Journal of Burn Care and Research 38 (2017), e165–e171.
44. Rosenthal, E., Beyond buds: Marijuana extracts — hash, vaping, dabbing edibles and medicines. 2014, Quick Trading Company.
45. Schuermeyer, J., Salomonsen-Sautel, S., Price, R.K., Balan, S., Thurstone, C., Min, S.J., et al. Temporal trends in marijuana attitudes, availability and use in Colorado compared to non-medical marijuana states: 2003–11. Drug and Alcohol Dependence 140 (2014), 145–155.
46. Sevigny, E.L., Pacula, R.L., Heaton, P., The effects of medical marijuana laws on potency. International Journal of Drug Policy 25 (2014), 308–319.
47. Small, E., Cannabis chemistry: Cannabinoids in cannabis, humans, and other species. Cannabis: A complete guide, 2016, CRC Press, 199–221.
48. Small, E., Medical marijuana: Production. Cannabis: A complete guide, 2016, CRC Press, 351–369.
49. StataCorp, Stata statistical software: Release 14. 2015, StataCorp LP, College Station, TX.
50. Stolzenberg, L., D'Alessio, S.J., Dariano, D., The effect of medical cannabis laws on juvenile cannabis use. International Journal of Drug Policy 27 (2016), 82–88.
51. Subritzky, T., Pettigrew, S., Lenton, S., Into the void: Regulating pesticide use in Colorado's commercial cannabis markets. International Journal of Drug Policy 42 (2017), 86–96.
52. Turner, J.C., Hemphill, J.K., Mahlberg, P.G., Gland distribution and cannabinoid content in clones of Cannabis-Sativa L. American Journal of Botany 64 (1977), 687–693.
53. U.S. Census Bureau Population Division. Annual estimates of the resident population: April 1, 2010 to July 1, 2016. Retrieved 2.24.17 from https://factfinder.census.gov/faces/nav/jsf/pages/index.xhtml.
54. Vandrey, R., Herrmann, E.S., Mitchell, J.M., Bigelow, G.E., Flegel, R., LoDico, C., et al. Pharmacokinetic profile of oral cannabis in humans: Blood and oral fluid disposition and relation to pharmacodynamic outcomes. Journal of Analytical Toxicology 41 (2017), 83–99.
55. Vandrey, R., Raber, J.C., Raber, M.E., Douglass, B., Miller, C., Bonn-Miller, M.O., Cannabinoid dose and label accuracy in edible medical cannabis products. JAMA 313 (2015), 2491–2493.
56. Wang, G.S., Roosevelt, G., Le Lait, M.C., Martinez, E.M., Bucher-Bartelson, B., Bronstein, A.C., et al. Association of unintentional pediatric exposures with decriminalization of marijuana in the United States. Annals of Emergency Medicine 63 (2014), 684–689.
57. Weisheit, R.A., The intangible rewards from crime — The case of domestic marijuana cultivation. Crime & Delinquency 37 (1991), 506–527.
58. Wen, H., Hockenberry, J.M., Cummings, J.R., The effect of medical marijuana laws on adolescent and adult use of marijuana, alcohol and other substances. Journal of Health Economics 42 (2015), 64–80.
59. Williams, A.R., Olfson, M., Kim, J.H., Martins, S.S., Kleber, H.D., Older: Less regulated medical marijuana programs have much greater enrollment rates than newer ‘Medicalized’ programs. Health Affairs (Millwood) 35 (2016), 480–488.